Carbohydrates

  • Composed of carbon, hydrogen and oxygen
  • Are water soluble
  • Are important source of energy for the body’s mechanisms
  • Classifications:
    • Monosaccharides: Glucose, fructose and galactose
    • Disaccharides: maltose (glucose + glucose), lactose (galactose + glucose) and sucrose (fructose + glucose; most common non reducing sugar)
    • Polysaccharides: starch and glycogen

GLUCOSE

  • Primary sugar found circulating in the body
  • Carbohydrate metabolism:
    • Glycolysis: glucose à lactate or pyruvate à energy (↑ glucose)
    • Glycogenolysis: breakdown of glycogen to glucose (↑ glucose)
    • Glycogenesis: formation of glycogen from sugars for storage (↓glucose)
    • Gluconeogenesis: formation of glucose from non-carbohydrate sources (↓ glucose)
  • Hormones for glucose regulation
    • Hypoglycemic
      • Insulin – released by β cells of islet of Langerhans
        • Entry of glucose in the cell
        • Falsely low measurement of serum insulin is seen in the presence of
    • Hyperglycemic
      • Glucagon – released by α cells of islet of Langerhans
        • Primary hormone that increases glucose concentration.
        • NV in fasting plasma: 25-50pg/mL
      • Somatostatin – released by delta cells of islet of Langerhans
        • Inhibits the action on inulin, GH and glucagon.
      • Cortisol
      • Epinephrine
      • Growth hormone
      • Thyroxine
      • ACTH
  • MUST KNOW FOR SPECIMEN FOR GLUCOSE DETERMINATION
    • FBS should be obtained from an 8-10 hours fasting sample
    • In terms of glucose levels: capillary > venous but < arterial
    • Glucose is metabolized at:
    • Room temperature: 7 mg/dL/hr
    • 4°C: 2 mg/dL/hr

GLUCOSE DETERMINATION

I. Chemical Method

  1. Chemical Method
    1. Alkaline Copper Reduction Method
      • Folin Wu – Modification: Benedict Test
        • Principle: Copper Reduction
        • Reagents
          • Alk. Copper reagent
          • Phosphomolybdic Acid
        • End Color / Color Reaction: Molybdenum – BLUE
      • Nelson- Somogyi
        • Principle: Copper Reduction
        • Reagents
          • Alk. Copper reagent
          • Arsenomolybdic acid
          • End Color / Color Reaction: Molybdenum – BLUE
      • Neocuproine
        • Principle: Copper Reduction
        • Reagents
          • Cuprous ions
          • Neocuproine
        • End Color / Color Reaction: Cuprous-Neocuproine Complex – YELLOW/ YELLOW ORANGE
    2. Alkaline Ferric Reduction Method
      • Autoanalyzer (Hagedorn-Jensen)
        • Principle: Ferricyanide reduction (Inverse Colorimetry)
        • Reagents: K3Fe(CN)6
        • End Color / Color Reaction: K3Fe(CN)6-4
  2. Condensation Method
      • Ortho-Toluidine
        • Principle: Dubowski reaction; Condensation Method
        • Reagent: 
          • O-toluidine
          • Glacial Acetic Acid
        • End Color / Color Reaction: Glycosylamine – BLUE GREEN

II. Enzymatic Method

      • Glucose Oxidase
        • Saifer Gernstenfield 
        • Clarke electrode
        • Principle: 
          • Enzymatic 
            • Colorimetric 
            • Polarographic
        • Reagents: 
          • Glucose Oxidase
          • Peroxidase
          • O-dianisidine
        • End Color / Color Reaction: Oxidized o-dianisidine – ORANGE BROWN
      • Hexokinase (REFERENCE METHOD)
        • Principle: Enzymatic 
        • Reagents:
          • Hexokinase
          • G6PD
        • End Color / Color Reaction: NADPH+

 

LABORATORY TESTS

  • Screening Tests
    • Fasting Blood Sugar – 8-10 hours fasting
      • Normal: <100 mg/dL
      • Impaired fasting glucose: 100-125 mg/dL
      • Diabetic: >126 mg/dL
    • 2-hours post-prandial – a fasting blood samples is extracted, after which, patient is given glucose load (75g). After 2 hours, blood glucose is measured.
      • Normal: <140 mg/dL
      • Impaired: 140-199 mg/dL
      • Diabetic: > 200 mg/dL
  • Confirmatory Tests
    • Oral Glucose Tolerance Test – series of glucose testing
      • Patient is instructed to consume a normal to high CHO diet per day for 3 days prior to procedure
      • Patient should be ambulatory
      • The patient should be finished within 5 minutes
      • Glucose loads: adult (75g), pregnant (100g) and children (1.75g/kg)
      • Normal: <140 mg/dL
      • Impaired: 140-199 mg/dL
      • Diabetic: > 200 mg/dL
  • Monitoring Test
    • HbA1c – long term monitoring (2-3 months)
      • Dependent upon the patients’ RBCs lifespan
      • Sample: EDTA whole blood, non-fasting
      • For every 1% increase in HbA1c = 35mg/dL change in plasma glucose!
    • Fructosamine – short term monitoring (2-3 weeks)
      • Levels of albumin affects results

CLINICAL SIGNIFICANCE

HYPERGLYCEMIA

Increased glucose levels

DIABETES MELLITUS

DIABETES INSIPIDUS

Involvement of insulin

Involvement of ADH

Polyuria

Polyuria (with no hyperglycemia)

High specific gravity urine

Low specific gravity urine

DIABETES MELLITUS

TYPE 1

TYPE 2

Autoimmune process

Resistance to insulin

Insulin-dependent DM

Non-insulin dependent DM

Juvenile-onset DM

Adult-onset DM

HYPOGLYCEMIA

Decreased glucose levels

Whipple’s triad:

  • Low blood glucose level (<60 mg/dL)
  • Presence of signs and symptoms
  • Reversal of symptoms (if glucose is administered)

GESTATIONAL DM

Due to hormonal imbalance; occurs in pregnant women

 

GLYCOGEN STORAGE DISEASES

TYPE

DEFECTS

Ia – Von Gierke

Glucose-6-phosphatase

II – Pompe

Lysosomal acid alpha glucosidase (GAA) acid maltase

III – Cori-Forbes

Glycogen debranching enzyme

IV – Andersen

Glycogen branching enzyme

V – McArdle

Muscle phosphorylase

VI – Hers

Glycogen phosphorylase

VII – Tarui

Phosphofructokinase

XI – Fanconi-Bickel

Glycogen transporter 2

0

Glycogen synthetase